Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $20.95 Analyst target: $23.00 Upside: 9.79%
Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. The company is headquartered in Bedford, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.